background: In order to optimize IVF strategies, particularly with the use of single embryo transfer, good predictive models are required. Here, we develop a model to allow such prediction, and the structure of the models point to more general conclusions about the mode of action of prognostic factors. results: Age, number of embryos created, attempt number, previous history of pregnancy, duration of infertility, day of transfer and tubal diagnosis were all identified as significant prognostic factors, along with embryo grade and growth rate. Frozen transfers were substantially less likely to lead to a live birth with odds ratios of 1/3 to 1/2 compared with fresh transfers, with no evidence of differential loss for any particular patient group. Age acts predominantly through the embryo component with only a weak effect on the uterus. The embryo number, attempt number, previous pregnancies and duration of infertility act predominantly through the uterine environment. Both submodels show significant heterogeneity between centres.
Introduction
A number of authors have developed predictive models for outcomes from IVF treatments, although only a few attempts have been able to include embryo factors in a statistically rigorous manner. In recent years, statistical approaches have been developed, principally the so-called embryo-uterus (EU) model, that allow proper inclusion of individual embryo factors while accounting for the correlations in outcome between embryos implanted on the same occasion (Zhou and Weinberg, 1998; Dukic and Hogan, 2002; Hunault et al., 2002a; Roberts, 2007) . To date, analyses using these approaches have been utilized in modestly sized single centre data sets, and have not had the statistical power to fully exploit the richness inherent in the models. The present study was part of a larger project to develop and exploit predictive models to investigate policy options around single embryo transfer (SET). It specifically aimed to develop a predictive model which would fully include measures of embryo grade and would maximize the clinical and biological information obtained from the resultant models.
The EU model contains two sub-models. The E sub-model represents the probabilities of an embryo being viable, given the embryo and patient characteristics and with a viable uterine environment. The U sub-model represents the probability of the woman being able to sustain a viable embryo, given the patient characteristics and the successful transfer of that embryo by the practitioner. Thus, the U component captures a range of maternal, treatment and cycle influences that potentially affect both embryos equally, and (despite its historical name) not just uterine receptivity. In any embryo-transfer (ET) cycle, each embryo may or may not be viable and uterine environment may or may not be suitable, with the probabilities of these events being given by the E and U submodels. A successful outcome requires both a successful embryo and a successful uterine environment. The E and U both potentially depend on patient and treatment characteristics, and these characteristics are included as logistic regression models for the E and U probabilities.
EU models have been utilized to model IVF treatment success by a number of authors (e.g. Zhou and Weinberg, 1998; Hunault et al., 2002a,b; Roberts et al., 2009) . One particular strength of these models is that they allow the computation of potential treatment outcomes where different numbers of embryos are transferred . The work described here is the development of an EU model that will ultimately allow such predictions across a wide range of treatment scenarios, with this paper describing the model development and properties.
One particular aspect of the EU modelling is that treatment parameters can, in principle, affect either or both the E and U components. As noted in earlier work , the data sets used previously have not been large enough to identify whether any particular factor should be included in the E, U or both components nor how parameters such as age may differentially affect the embryo viability and uterine environment. Previous work has made rather arbitrary assumptions as to how to distribute covariates between the two sub-models (Hunault et al., 2002b; Roberts et al., 2009) . Including parameters in either or both the E or U sub-models does yield different estimates of the relative proportions of singleton and multiple births when more than one embryo is transferred, so it is theoretically possible to identify the most appropriate sub-model for any parameter, but this identification is weak and requires large data sets. One aim of the work described here was to collate a large enough data set to be able to test whether any reliable conclusions could be drawn as to how parameters affected the E or U components.
We describe the collation of a large multi-centre data set based on routinely recorded data and the development of a predictive EU model. The properties of the model are described with particular reference to the embryo or uterine components, and some validation is presented. Future publications will describe the use of this model in predicting the outcomes of SET versus double ET (DET).
Materials and Methods

Data extraction and cleaning
Anonymized data were extracted for ET cycles from the clinic databases in 5 UK Assisted Conception Units (Supplementary data, Table S1 ) for the 2000 -2005 period and assembled into a common format. From these data IVF/ICSI transfer cycles from patients aged 19 -54 recorded as having started trying to achieve pregnancy after 1980 were selected. Cycles using donor or frozen oocytes, or natural induction or more than three transferred embryos were excluded. Additionally, we defined a core set of covariates (listed in Table I ) and cycles were excluded if any of these variables were missing.
Normalization of embryo grading
The five centres used similar morphological embryo grading criteria, modified from Steer et al. (1992) . Grades are ordered 1 -4 with 4 being the best. Preliminary exploratory analysis suggested, however, that the grading schemes were not applied consistently between the centres: the proportions given to each grade differed significantly, and EU models incorporating grade showed a significant grade by centre interaction indicating that embryos of differing viability were graded similarly between different laboratories. Therefore, embryo grades were normalized based on an assumption that the underlying embryo grade distribution was the same across sites and computing a site-specific score to each site to maintain this condition. This normalization was justified post-hoc by the lack of centre by grade interaction in the fitted models, that is, after normalization there was no longer any evidence of differential outcomes between centres for embryos of the same grade. Additionally, examination of the observed versus fitted data per site showed no systematic lack of fit.
The embryo cell number was represented as a doubling time computed as log 2 (cells)/(days in culture), using the recorded time in culture. Where culture time was unavailable a mean value, given the transfer day, was used. This representation allows Day 2 and Day 3 embryos to be assessed on the same scale.
Building the models EU models were fitted to the data set with the number of live births as the outcome variable. The structure of the model and technical details of the model fitting and statistical inference have been described elsewhere (Roberts, 2007; Roberts et al., 2009) . Briefly the E and U are represented by logistic regression sub-models and combined to give the number of live births for each ET procedure. The model explicitly includes the correlations between embryos implanted at the same time both through the U component and through common covariate values. The model is fitted using direct maximization of the resultant observed data likelihood.
The variables for inclusion in the model were pre-selected on the basis of previous knowledge and the data available and are listed in Table I . Embryo grade and cell doublings were represented by cubic spline functions with three degrees of freedom. These choices were justified posthoc as increasing the spline degrees of freedom did not improve the fit as assessed by the Akaike information criterion (AIC). Age, embryo number, attempt and duration of infertility were represented as categorical variables with the grouping chosen to avoid small numbers in any one group. A simplified variable denoted as 'pregnancy history' was defined with four levels: never pregnant (natural or IVF), previously pregnant, one previous live birth and more than one previous live birth.
Each of the variables can, in principle, be included in either or both the E and U models, that is, they can affect the embryo viability or the uterine receptivity. Model selection was clinically guided, and the best fitting of the competing models was selected using the AIC (see Supplementary data, Appendix S1 for details of the procedure). For formal comparisons, each variable was then permuted in turn through all possible assignments holding the other variables in their selected sub-model(s).
Potential interactions between the major prognostic variables (age, embryos created, site, grade and growth rate) were considered. Models were fitted with the additional interaction terms and the change in AIC was computed. One borderline significant interaction was observed, and is reported, but considered to be of minor clinical significance and so was not included in the model presented.
Likelihood ratio (x 2 ) tests were used to assess the statistical significance of model parameters.
Embryo and uterine influences on IVF outcomes
Inter-cycle correlations
In order to explore the impact of correlations between cycles from the same individuals, we considered models in which couple-specific random effects were added to the U sub-model. These were fitted using adaptive quadrature. However, this is very computationally intensive and was not practical for the full fitted model so a composite predictor was derived for each sub-model (the linear predictor of the logistic model) and used as a single covariate in each sub-model.
Frozen transfers
A priori we expected that there would be strong inter-centre heterogeneity in the outcomes of frozen transfers, and this was confirmed in Number of multiple birth outcomes and percentage of live birth events. preliminary analyses. Data for frozen transfers were only available in a useful form from three of the centres. Additionally, it was not possible to include the growth rate in frozen transfers as the full embryo histories were not available. Therefore, we included fresh cycle growth and an interaction between site and cryopreservation as a single six-level factor with the growth rate categorized as slow (,0.99 doublings/day), normal or fast (.1.07 doublings/day) plus a level for frozen embryos from each of the three included centres. The age of the mother at oocyte retrieval was used in the E sub-model and that of the mother at the time of transfer was used in the U sub-model.
Statistical analysis
All analyses were performed using custom-written code in the R statistical environment (R Development Core Team, 2008) .
Results
Characteristics of the data set
Nineteen thousand three hundred and seventy-three ET cycles were extracted from the databases in the five centres (see Supplementary data, Table S1 ). After data selection and cleaning, the total number of ET cycles available for analysis was 16 096: 12 487 fresh and 3609 frozen, from 8775 couples. The characteristics of the analysis data set are shown in Table I . These characteristics are close to those of a national cohort covering the same period (Roberts et al., 2010) , indicating that this is a representative sample of a UK IVF treatment during the study period.
The EU model
Age, treatment year and centre were included in both the E and U sub-models. Sperm source and use of ICSI were pre-specified to be included in the E sub-model only. The model selection process assigned the number of embryos transferred, the day of transfer and male factor infertility to the E sub-model, while the number of embryos created, attempt number, pregnancy history, duration of infertility and maternal diagnoses were assigned to the U sub-model. Table II shows the parameter estimates from the final selected model for the patient and clinical characteristics, while the estimates for the embryo characteristics are available (Supplementary data, Fig. S1 ). Supplementary data, Appendix S2 gives the details necessary to compute predictions from the model, and an R function can be obtained from the author.
Figures 1 and 2 show the predicted outcomes for the most important predictors, for an otherwise typical patient (all other variables held at their reference level, optimal embryos) and the range of predicted outcomes in the data set. It is instructive to note that for any predictor there is a wide range of live birth probabilities-no one predictor is dominant. Parameter estimates are shown in Table II . Figure 1 shows the expected strong relationship with embryo growth, with both slow-and fast-growing embryos having a poor implantation probability compared with those with a normal growth of around 1 doubling per day. Morphological grade also shows the expected relationships, with grades 1 and 2 having very poor prognosis and grades 3 and 4 similar, but good, prognosis.
Success declines steeply after female age 30 (Fig. 2) . The number of embryos created is a strong predictor of treatment success, with an odds ratio of 2 in embryo viability between many and a single embryo created. This is compounded by the fact that if there are few embryos created, there is less chance of a top quality embryo and thus the patients with small numbers of embryos do particularly badly, as demonstrated by the steeper fall-off in population estimates compared with the pure parameter effects. Patient history variables show modest, but significant, prognostic ability. The use of ICSI per se does not significantly predict outcome in this series, after embryo quality and the other factors are taken into consideration, neither does the use of donor sperm or male factor infertility, although all these variables are interrelated. The only female diagnosis significantly associated with outcome is tubal with those with such a diagnosis having modestly poorer outcomes. There are moderately strong effects of the centre and the year, which may reflect population or treatment changes. Although we identified no significant policy differences either between centres or across years, the centres do differ in the proportions of NHS and fee-paying patients and in commissioning and referral processes. Figure 3 shows the parameters and predictions for the E and U submodels separately for the three variables fitted in both sub-models. The age effect is stronger in E than it is in U. The centre and year effects are complex and difficult to interpret as both practice and patient populations are continually evolving.
Do prognostic factors act on the embryo or the recipient?
The model selection process described above assigned each of the model parameters to one or both of the sub-models. In Table III , we show the AIC measures for variations in which each parameter in turn is fitted in each of the four possible sub-model combinations with the remaining factors fitted in their 'optimal' sub-model. Here, we consider an AIC difference .2 as providing evidence that one model is to be preferred, this being the criterion by which an additional model parameter would be justified. There is evidence that a better fit to the data would be achieved if the age effect were confined to the E sub-model only. This is demonstrated visually in Fig. 3 , where the age effect is stronger in the E component. Although somewhat dependent on the parametrization, this suggests that there is no clear evidence that age affects the receptivity, while there is strong evidence that it acts through the embryo viability. There is good statistical evidence that the assignment of the number of embryos created, attempt number, pregnancy history and duration of infertility to the U sub-model are appropriate and that there is no significant E effect for these factors. Centre effects clearly affect both the E and U components, but the year is more equivocal. Tubal diagnosis is identified as a U effect, while the other diagnoses and the use of ICSI were non-significant and cannot be assigned to either model with any reliability.
Model validation
The observed versus fitted values for the selected model show no systematic lack of fit (see Supplementary data, Fig. S2 and Table S3 ). A formal measure of the goodness of fits is given by the area under the ROC curve (AUC). As we have a multinomial outcome, there are three AUC parameters, one for each of treatment failure, singleton and twin outcomes. These are shown in 
An interaction model
All two-way interactions between the major predictors were tested. The model with an age by embryo grade interaction was a slightly better fit to the data than the selected model. A likelihood ratio test gives P ¼ 0.020, which would not be considered statistically significant if we allowed for the fact that a number of interactions were tested. The interaction indicates that the effect of grade is somewhat weaker in the older patients, i.e. grade is not as good a predictor of success above 35 as it is in younger patients.
Modelling of the effect of frozen cycles
Data for fresh and frozen cycles were fitted together with a six-level factor in the E sub-model combining fresh cell growth and freezing. We also considered a simple fresh/frozen parameter in the U component but the fitted estimate (20.2) was negligible and did not reach statistical significance (P ¼ 0.3). The parameter estimates for the freezing-related variables are shown in Table V . The loss due to freezing is substantial, with embryo implantation odds ratios between 1/3 and 1/2, and quite large differences between the three centres. Formal interaction tests between the main covariates and the cycle type (fresh or frozen) revealed no evidence that this loss depended on clinical or patient characteristics.
Inter-cycle correlations
The correlation between cycles from the same couples can be represented by a couple random effect in the U sub-model. This can be thought of as a composite of all the unmeasured covariates that are specific to that couple. Using a simplified model based on the combined predictors of E and U, we can estimate this effect (RE) for repeat cycles from the same couples. This gave estimates of the RE of 0.69 (95% CI: 0-1.11), P ¼ 0.06, between repeat fresh cycles and 0.82 (0-1.41), P ¼ 0.09, between fresh and frozen cycles. Including these RE did not materially alter the other parameter estimates.
Discussion
Limitations and caveats
The models developed here relate to outcomes of individual ET procedures and not the more relevant clinical outcomes across a treatment course. A full treatment course may include several oocyte retrieval and transfer procedures, involving both fresh and frozen embryos. However, given the estimates of the inter-cycle random effects, it may be possible, with arguably reasonable assumptions, to simulate such multi-cycle outcomes. Embryo and uterine influences on IVF outcomes
The study was designed to use routinely collected data which were recorded into commercially developed clinical databases, and as such was believed to be robust and accurate. However, in practice, we found serious limitations with this approach, particularly regarding the linkage of data across multiple oocyte collection and ET cycles. We also note that there was a non-trivial amount of missing and invalid data, and that we were not able to extract as many potential covariates as we would have wished. However, we have found no evidence that the missing data will have biased the results: as far as we can determine, it was missing effectively at random. More covariates may have improved the predictive power of the models, and further work is required to test any additional covariates.
The centres recruited all used nominally similar embryo grading schemes, based on the same criteria, although the numerical scores were inverted in some sites relative to the rest. However, it was clear that the implementations were not identical, and a normalization had to be employed with a strong assumption that the underlying embryo grade distributions were similar between sites. Although post hoc tests and examination of the fits did not show any site differences in grading after the normalization, this nonetheless may have introduced subtle biases, in particular to the inter-centre comparisons. Such variability is not unexpected (Matson, 1998; Cutting et al., 2008) and for future studies the use of a consistent and quality-controlled grading system is clearly indicated (Cutting et al., 2008) ; such a pilot scheme has recently been launched by the UK Association of Clinical Embryologists.
The EU model allowed us to identify the level at which a number of the covariates act: embryo or recipient. While this gives results that appear reasonable and have some statistical support, more methodological work is required to understand this and validate whether this identification is real and its sensitivity to the model assumptions and data structures. The EU model has itself a number of assumptions which it is not possible to test formally, although there was no evidence of any systematic lack of fit to indicate that the model is not valid. Monozygotic twins are not included in the model and not considered.
Finally, we note that this data were derived from the 2000-2005 time period. The data and results are generally consistent with that from the national database from the same period. Although clinical practice has altered in terms of the proportions of elective SET and blastocyst transfer performed and success rates have improved slightly since that time, practice around the Day 2/3 transfers has not changed appreciably. Further work is required to validate these models with more recent data as they become available.
Prognostic factors
As would be expected, age is the major predictor of success, with an accelerating decline from around age 32 and very low success rates by age 43 -45. The age effect is stronger on the E component than the U, i.e. it is the embryo age that is most important. The evidence for a significant U component is ambiguous: we note that in a model with few other covariates suggested age should be in both sub-models while the large number of parameters associated with age in our selected model will have increased the AIC and a simpler age function may well have warranted inclusion. Studies of the recipients of donor oocytes find that similarly recipient age is only a weak predictor of outcome, but as in the present data there is a fall-off in success for women in their forties (Legro et al., 1995; Stolwijk et al., 1997; Toner et al., 2002) .
The number of embryos created shows good evidence as contributing through U, suggesting that it may be a surrogate marker for hormonal factors (Nardo et al., 2009) . Attempt number, though a weak effect, acts through U also, possibly suggesting that the systematic decline in success with later attempts reflects poorer uterine or hormonal environments in these patients. However, interpretation of multiple attempts is difficult in these data as the later attempts are predominantly from patients who have failed earlier attempts but have funding for more, and so there are large selection effects. Pregnancy and infertility history both seem to reflect uterine environment rather than embryo factors. Most of the diagnoses have little impact on the outcome, but a tubal diagnosis was significantly associated with a poorer outcome as noted previously (Strandell et al., 2000) , and unsurprisingly acts through the uterine component. Site and year of treatment both contribute strongly to both components, suggestive of variations in both clinical and embryological practice and perhaps patient population between centres and over time. There is weak evidence that the use of donor sperm should be included in the U rather than the E sub-model, but stronger evidence that it could be excluded entirely; although at face value donor sperm can only affect embryos, it does reflect a male cause to the infertility and may therefore be a surrogate marker for better maternal factors, and so either is plausible.
We see that there is the expected strong relationship of outcome with embryo growth, with both slow-and fast-growing embryos having a poor implantation probability compared with those with a normal growth of around 1 doubling/day. This is consistent with the concept that an optimal doubling (or cell cycle) time is required for viability, and faster (shorter) cell cycle times may be problematic if cell cycle checkpoints do not function effectively. This has been observed previously (Testart, 1986; Giorgetti et al., 1995; Roberts et al., 2009 ). The morphological grade shows the expected relationships, with grades 1 and 2 having very poor prognosis and grades 3 and 4 similar, but good, prognosis.
There is little evidence of a consistent improvement over time in this cohort. There were quite large differences between the five centres included in the data set and it is interesting that treatment centre affects both the embryo and uterine components. The differences between patients treated in the various centres are not Figure 3 Predictions of uterine viability (U ) and embryo implantation probability (E) for predictors appearing in both the E and U sub-models.
Embryo and uterine influences on IVF outcomes explained by the covariates in the model, but may still reflect patient selection effects or subtle differences in embryo grading not accounted for in the normalization and not differences in treatment quality. Centres with high E relative to the U will produce more twins per live birth, as is observed. That is, we do see some evidence of higher twin rates in fresh DET in some centres compared with others although the overall live birth rates are quite similar. Whilst different population characteristics cannot be ruled out, this may suggest that centres may have preferentially optimized either their treatment strategy, the embryology or the clinical components of treatment to achieve acceptable success rates. If both the factors affecting E and U could be optimized, then it is possible that further gains in treatment outcomes could be achieved. It is noteworthy that efforts to optimize embryo quality will lead to higher twin rates in DET cycles.
Although the statistical evidence is weak for non-zero correlations between cycles in this data set, the magnitude of these intra-patient correlations are not precisely determined and the correlation estimates are of a magnitude that is clinically relevant. The estimated standard deviations of patient (or oocyte collection) specific effects are on the same linear predictor scale as the model parameter estimates (b) and thus these effects can be seen to be smaller than the differences due to age and embryo quality, but larger than (for example) the effects of patient history or diagnosis.
The potential interaction between grade and age is, we believe, a novel observation, although of borderline statistical significance if we allow for the fact that a number of such interactions were tested. While this could be an artefact of the grading systems or the normalization procedure required to unify data between centres, it is biologically plausible if there are important age-related components of embryo viability that are not detectable by the morphological systems employed here. Genetic abnormalities such as aneuploidy are an obvious candidate here as the incidence of these increase strongly with maternal age, but the correlation between aneuploidy and embryo morphology is less strong (Munne et al., 2007) .
Impact of cryopreservation
The impact of cryopreservation cannot be reliably determined from this data set as weaknesses in the data mean that it is not possible to fully model frozen cycles: factors such as pre-and post-freezing culture times are not recorded, and for two of the centres it was not possible to identify the oocyte collection corresponding to the frozen transfer. We therefore only attempted to estimate a simple loss factor for frozen cycles, although importantly we were able to see that the prognostic factors generally behaved similarly to those in fresh cycles. Because of the strong caveats, and the fact that cryopreservation techniques and practice may have been expected to have evolved since the time of this data set, we believe the estimates here form a lower bound on the success of frozen cycles; better success rates are likely to be achievable. This is evidenced by the large variation between the centres, suggesting that practice differences may be important. Furthermore, any rigorous analysis of freezing policies must take into account the whole treatment course with an appropriate cumulative outcome measure. 
EU modelling
As far as we are aware, this is the first study to attempt to distinguish embryo and uterine factors. While statistical hypothesis tests can formally evaluate whether a parameter affects both E and U, either E or U or has no effect (so-called 'nested' models), there is no formal test to determine whether an assignment to E or U (the non-nested case) is real or a chance finding, and our arbitrary criterion of an AIC change of two has little theoretical or experiential justification. More theoretical or simulation work is required to understand how to assess the strength of evidence for these assignments. This is also the first attempt to look at inter-cycle correlations within an EU framework, although computational constraints mean that we cannot explore these systematically, and can only consider a single effect in the U sub-model in a simplified covariate structure. Further methodological work is required to enable these effects to be explored further.
Conclusions
The analysis here confirms the role of the prognostic factors seen in other studies. The data from frozen cycles are of limited quality, but the analyses do indicate a significant loss in success rates associated with freezing, with no dependence on treatment or patient characteristics being observed.
For the first time, we have been able to provide statistical evidence that some prognostic factors, including age, act primarily through the embryo viability, while others, including the number of embryos created and patient history, principally act through the uterine receptivity. Variability in the two components between centres with similar overall outcomes suggests that there may be scope for further optimization of IVF treatment.
